Woman and Man
- | Country : -
- | organs : -
- | Specialty : -
Extract
To assess the safety and tolerability of peptide receptor radionuclide therapy (PRRT) with 177Lu-OPS201 administered in three cycles in patients with somatostatin receptor positive NETs (including phaechromocytomas and paragangliomas).
Inclusion criteria
- Neuroendocrine tumors (NETs)